rawfin.tv
Outlook Therapeutics CEO Granted 100,000 Stock Options
MarketsstocksAI Generated

Outlook Therapeutics CEO Granted 100,000 Stock Options

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Outlook Therapeutics CEO Robert Charles Jahr received a grant of 100,000 stock options. The options were issued with an exercise price of $1.4.

OTLKExecutive CompensationStock OptionsBiotechCorporate Governance

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks